Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.

ABSTRACT: This article summarizes the molecular and cellular mechanisms that regulate the activity of indoleamine 2,3-dioxygenase (IDO), a potent immune-suppressive enzyme, in dendritic cells (DCs). Specific attention is given to differential up-regulation of IDO in distinct DC subsets, its function in immune homeostasis/autoimmunity, infection and cancer; and the associated immunological outcomes. The review will conclude with a discussion of the poorly defined mechanisms that mediate the long-term maintenance of IDO-expression in response to inflammatory stimuli and how selective modulation of IDO activity may be used in the treatment of disease.

SUBMITTER: Harden JL 

PROVIDER: S-EPMC3645912 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature